These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 9223665

  • 1. Serum starved v-mos-transformed cells are unable to appropriately downregulate cyclins and CDKs.
    Rhodes N, Innes CL, Propst F, Paules RS.
    Oncogene; 1997 Jun 26; 14(25):3017-27. PubMed ID: 9223665
    [Abstract] [Full Text] [Related]

  • 2. Deregulation of specific E2F complexes by the v-mos oncogene.
    Afshari CA, Rhodes N, Paules RS, Mudryj M.
    Oncogene; 1997 Jun 26; 14(25):3029-38. PubMed ID: 9223666
    [Abstract] [Full Text] [Related]

  • 3. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes.
    Lucas JJ, Szepesi A, Domenico J, Tordai A, Terada N, Gelfand EW.
    J Cell Physiol; 1995 Nov 26; 165(2):406-16. PubMed ID: 7593219
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 26; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 5. [Lys61]N-Ras is able to induce full activation and nuclear accumulation of Cdk4 in NIH3T3 cells.
    Villalonga P, Rius E, Bachs O, Agell N.
    Oncogene; 2000 Feb 03; 19(5):690-9. PubMed ID: 10698514
    [Abstract] [Full Text] [Related]

  • 6. v-mos-transformed cells fail to enter quiescence but growth arrest in G1 following serum withdrawal.
    Rhodes N, Hicks R, Kasenally AB, Innes CL, Paules RS, Propst F.
    Exp Cell Res; 1994 Jul 03; 213(1):210-7. PubMed ID: 8020593
    [Abstract] [Full Text] [Related]

  • 7. BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases.
    Greider C, Chattopadhyay A, Parkhurst C, Yang E.
    Oncogene; 2002 Nov 07; 21(51):7765-75. PubMed ID: 12420213
    [Abstract] [Full Text] [Related]

  • 8. Increased G1 cyclin/cdk activity in cells overexpressing the candidate oncogene, MCT-1.
    Dierov J, Prosniak M, Gallia G, Gartenhaus RB.
    J Cell Biochem; 1999 Sep 15; 74(4):544-50. PubMed ID: 10440924
    [Abstract] [Full Text] [Related]

  • 9. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ, Higgins T, Jones NC, Rozengurt E.
    Oncogene; 1997 Apr 17; 14(15):1759-66. PubMed ID: 9150381
    [Abstract] [Full Text] [Related]

  • 10. Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity.
    Berns K, Hijmans EM, Bernards R.
    Oncogene; 1997 Sep 17; 15(11):1347-56. PubMed ID: 9315103
    [Abstract] [Full Text] [Related]

  • 11. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A, Washington Parks R, Rivadeneira E, Franchini G.
    Oncogene; 1999 Apr 15; 18(15):2441-50. PubMed ID: 10229195
    [Abstract] [Full Text] [Related]

  • 12. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA, DeLorenzo RJ, Tombes RM.
    Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994
    [Abstract] [Full Text] [Related]

  • 13. Fos proteins can act as negative regulators of cell growth independently of the fos transforming pathway.
    Balsalobre A, Jolicoeur P.
    Oncogene; 1995 Aug 03; 11(3):455-65. PubMed ID: 7630629
    [Abstract] [Full Text] [Related]

  • 14. Transformation by v-Jun prevents cell cycle exit and promotes apoptosis in the absence of serum growth factors.
    Clark W, Gillespie DA.
    Cell Growth Differ; 1997 Apr 03; 8(4):371-80. PubMed ID: 9101083
    [Abstract] [Full Text] [Related]

  • 15. Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine.
    Gollapudi L, Neet KE.
    J Neurosci Res; 1997 Aug 15; 49(4):461-74. PubMed ID: 9285522
    [Abstract] [Full Text] [Related]

  • 16. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles.
    Baptist M, Lamy F, Gannon J, Hunt T, Dumont JE, Roger PP.
    J Cell Physiol; 1996 Feb 15; 166(2):256-73. PubMed ID: 8591985
    [Abstract] [Full Text] [Related]

  • 17. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G, Hunter T, Ruoslahti E.
    Oncogene; 1998 May 15; 16(20):2575-83. PubMed ID: 9632134
    [Abstract] [Full Text] [Related]

  • 18. Mimosine arrests cells in G1 by enhancing the levels of p27(Kip1).
    Wang G, Miskimins R, Miskimins WK.
    Exp Cell Res; 2000 Jan 10; 254(1):64-71. PubMed ID: 10623466
    [Abstract] [Full Text] [Related]

  • 19. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after gamma-irradiation.
    Bulavin DV, Tararova ND, Aksenov ND, Pospelov VA, Pospelova TV.
    Oncogene; 1999 Oct 07; 18(41):5611-9. PubMed ID: 10523840
    [Abstract] [Full Text] [Related]

  • 20. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G, Barkan R, Popov B, Nikolsky N, Chang LS.
    Exp Cell Res; 2000 Aug 25; 259(1):35-53. PubMed ID: 10942577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.